Will TrumpRx actually lower drug prices?
On Point with Meghna Chakrabarti
00:00
Direct-to-Consumer Models vs. Middlemen
Avorn compares TrumpRx to other direct-sale efforts like Mark Cuban's cost-plus model and discusses bypassing PBMs.
Transcript
Play full episode
